Supported by the AI software, eko.ai is automating the process fighting against heart disease, by simplifying and democratizing ultrasound of the heart. Contributed by many clinician scientists, sonographers and deep learning experts, eko.ai becomes the most commonly used tool for the detection of cardiovascular risk through machine learning.
| Company Name | eko.ai |
|---|---|
| Brand Name | eko.ai |
| Industries | Healthcare BioTech |
| Year of Establishment | 2017 |
| Founder(s) | James Hare |
| No. of Employees | less than 10 |
| Regional Coverage | Singapore |
| Clients | / |
| Stage | Seed |
| Investor(s) | StartUp Health |
| Fundraising History | 1M USD (Feb 2018) |
| Raising Fund | / |
| Fundraising target | / |
| Pre-money valuation | / |
| Post-money Valuation | / |
| Media Exposure | Yahoo fi/ce HIT Consultant Medical Device and Diagnostics Industry Becker's Hospital Review Medical Design & Outsourcing FierceBiotech |
| Company Email | [email protected] |
[dcb id=160440]